Showing results (561-570 of 1,451) with videos related to
Sort By:
Pageof 146
Brain Stimulation|July 26, 2017
Systematic review of hardware-related complications of Deep Brain Stimulation: Do new indications pose an increased risk?Onanong Jitkritsadakul, Roongroj Bhidayasiri, Suneil K Kalia, et al.Comprehensive Psychiatry|May 24, 2024
Identifying internalizing transdiagnostic profiles through motivational and cognitive control systems: Relations with symptoms, functionality, and quality of lifeA Verdejo-Garcia, G Rossi, N Albein-Urios, et al.Journal of Neurosurgery|March 22, 2024
Comprehensive characterization of intracranial hemorrhage in deep brain stimulation: a systematic review of literature from 1987 to 2023Cletus Cheyuo, Artur Vetkas, Can Sarica, et al.Experimental Brain Research|November 13, 2002
Simultaneous repetitive movements following pallidotomy or subthalamic deep brain stimulation in patients with Parkinson's diseaseR Levy, A E Lang, W D Hutchison, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 22, 2011
Stereotactic techniques and perioperative management of DBS in dystoniaPhilip A Starr, Paul Bejjani, Andres M Lozano, et al.Journal of Clinical Microbiology|January 1, 1997
Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin BM Lozano-Chiu, P W Nelson, M Lancaster, et al.Psicothema|November 4, 2010
[In-group Bias Test adapted to the relative acculturation extended model: reliability and validity evidences]Antonio José Rojas Tejada, Marisol Navas Luque, Óscar M Lozano Rojas, et al.Journal of Neurosurgery|May 5, 2009
Microstimulation-induced inhibition as a tool to aid targeting the ventral border of the subthalamic nucleusMyriam Lafreniere-Roula, William D Hutchison, Andres M Lozano, et al.The New England Journal of Medicine|October 9, 1997
Posteroventral medial pallidotomy in advanced Parkinson's diseaseA E Lang, A M Lozano, E Montgomery, et al.Neurological Research|August 10, 1999
Inhibition of intra-tumoral angiogenesis and glioma growth by the fibroblast growth factor inhibitor 1,3,6-naphthalenetrisulfonateP Cuevas, F Carceller, D Reimers, et al.Pageof 146